Genetic alterations determine chemotherapy resistance in childhood T-ALL: Modelling in stage-specific cell lines and correlation with diagnostic patient samples

British Journal of Haematology

Volumn 139, Issue 1, 2007, Pages 20-30

  Estes, David A ^b   Lovato, Debbie M ^b   Khawaja, Hadya M ^b   Winter, Stuart S ^b   Larson, Richard S ^a,b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Daunorubicin; Drug resistance; L asparaginase; Leukaemia; T cell acute lymphoblastic leukaemia

Indexed keywords

ABC TRANSPORTER A1; ARGININOSUCCINATE SYNTHASE; ASPARAGINASE; ASPARTATE AMMONIA LIGASE; DAUNORUBICIN; PREDNISOLONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; T CELL LEUKEMIA; UPREGULATION;

ARGININOSUCCINATE SYNTHASE; ASPARAGINASE; ASPARTATE-AMMONIA LIGASE; CELL LINE, TUMOR; CHILD; DAUNORUBICIN; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; GENES, MDR; HUMANS; JURKAT CELLS; LEUKEMIA, T-CELL, ACUTE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; P-GLYCOPROTEIN; PREDNISOLONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING; VINCRISTINE;

EID: 34548550698     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06763.x     Document Type: Article

References (47)

1. Al Sarraj, J., Vinson, C. Thiel, G. (2005) Regulation of asparagine synthetase gene transcription by the basic region leucine zipper transcription factors ATF5 and CHOP. Biological Chemistry, 386, 873 879.
2. Amylon, M.D., Shuster, J., Pullen, J., Berard, C., Link, M.P., Wharam, M., Katz, J., Yu, A., Laver, J., Ravindranath, Y., Kurtzberg, J., Desai, S., Camitta, B. Murphy, S.B. (1999) Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study. Leukemia, 13, 335 342.
3. Aslanian, A.M., Fletcher, B.S. Kilberg, M.S. (2001) Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells. Biochemical Journal, 357, 321 328.
4. Beck, W.T. (1983) Vinca alkaloid-resistant phenotype in cultured human leukemic lymphoblasts. Cancer Treatment Reports, 67, 875 882.
5. Bene, M.C., Castoldi, G., Knapp, W., Ludwig, W.D., Matutes, E., Orfao, A. van't Veer, M.B. (1995) Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia, 9, 1783 1786.
6. Burger, R., Hansen-Hagge, T.E., Drexler, H.G. Gramatzki, M. (1999) Heterogeneity of T-acute lymphoblastic leukemia (T-ALL) cell lines: suggestion for classification by immunophenotype and T-cell receptor studies. Leukemia Research, 23, 19 27.
7. Czuczman, M.S., Dodge, R.K., Stewart, C.C., Frankel, S.R., Davey, F.R., Powell, B.L., Szatrowski, T.P., Schiffer, C.A., Larson, R.A. Bloomfield, C.D. (1999) Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: cancer and leukemia Group B study 8364. Blood, 93, 3931 3939.
8. Dallas, P.B., Gottardo, N.G., Firth, M.J., Beesley, A.H., Hoffmann, K., Terry, P.A., Freitas, J.R., Boag, J.M., Cummings, A.J. Kees, U.R. (2005) Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR - how well do they correlate? BMC Genomics, 6, 59.
9. Darzynkiewicz, Z. (1990) Differential staining of DNA and RNA in intact cells and isolated cell nuclei with acridine orange. Methods in Cell Biology, 33, 285 298.
10. De Moerloose, B., Swerts, K., Benoit, Y., Laureys, G., Loeys, T., Philippe, J. Dhooge, C. (2003) The combined analysis of P-glycoprotein expression and activity predicts outcome in childhood acute lymphoblastic leukemia. Pediatric Hematology and Oncology, 20, 381 391.
11. Den Boer, M.L., Pieters, R. Veerman, A.J. (1998) Mechanisms of cellular anthracycline resistance in childhood acute leukemia. Leukemia, 12, 1657 1670.
12. Den Boer, M.L., Harms, D.O., Pieters, R., Kazemier, K.M., Gobel, U., Korholz, D., Graubner, U., Haas, R.J., Jorch, N., Spaar, H.J., Kaspers, G.J., Kamps, W.A., Van der Does-Van den Berg, A., Van Wering, E.R., Veerman, A.J. Janka-Schaub, G.E. (2003) Patient stratification based on prednisolone- vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia. Journal of Clinical Oncology, 21, 3262 3268.
13. Dhooge, C., De Moerloose, B., Laureys, G., Kint, J., Ferster, A., De Bacquer, D., Philippe, J. Benoit, Y. (1999) P-glycoprotein is an independent prognostic factor predicting relapse in childhood acute lymphoblastic leukaemia: results of a 6-year prospective study. British Journal of Haematology, 105, 676 683.
14. Dhooge, C., De Moerloose, B., Laureys, G., Ferster, A., De Bacquer, D., Philippe, J., Leroy, J. Benoit, Y. (2002) Expression of the multidrug transporter P-glycoprotein is highly correlated with clinical outcome in childhood acute lymphoblastic leukemia: results of a long-term prospective study. Leukemia & Lymphoma, 43, 309 314.
15. Ding, Y., Li, Z. Broome, J.D. (2005) Epigenetic changes in the repression and induction of asparagine synthetase in human leukemic cell lines. Leukemia, 19, 420 426.
16. Efferth, T., Gillet, J.P., Sauerbrey, A., Zintl, F., Bertholet, V., de Longueville, F., Remacle, J. Steinbach, D. (2006) Expression profiling of ATP-binding cassette transporters in childhood T-cell acute lymphoblastic leukemia. Molecular Cancer Therapy, 5, 1986 1994.
17. Ferrando, A.A., Neuberg, D.S., Staunton, J., Loh, M.L., Huard, C., Raimondi, S.C., Behm, F.G., Pui, C.H., Downing, J.R., Gilliland, D.G., Lander, E.S., Golub, T.R. Look, A.T. (2002) Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell, 1, 75 87.
18. Fine, B.M., Kaspers, G.J., Ho, M., Loonen, A.H. Boxer, L.M. (2005) A genome-wide view of the in vitro response to l-asparaginase in acute lymphoblastic leukemia. Cancer Research, 65, 291 299.
19. Holleman, A., Cheok, M.H., den Boer, M.L., Yang, W., Veerman, A.J., Kazemier, K.M., Pei, D., Cheng, C., Pui, C.H., Relling, M.V., Janka-Schaub, G.E., Pieters, R. Evans, W.E. (2004) Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. New England Journal of Medicine, 351, 533 542.
20. Hongo, T., Yajima, S., Sakurai, M., Horikoshi, Y. Hanada, R. (1997) In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia. Blood, 89, 2959 2965.
21. Juliano, R.L. Ling, V. (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochimica et Biophysica Acta, 455, 152 162.
22. Kanerva, J., Tiirikainen, M., Makipernaa, A., Riikonen, P., Mottonen, M., Salmi, T.T., Krusius, T. Saarinen-Pihkala, U.M. (1998) Multiple drug resistance mediated by P-glycoprotein is not a major factor in a slow response to therapy in childhood ALL. Pediatric Hematology and Oncology, 15, 11 21.
23. Kanerva, J., Tiirikainen, M.I., Makipernaa, A., Riikonen, P., Mottonen, M., Salmi, T.T., Krusius, T. Saarinen-Pihkala, U.M. (2001) Initial P-glycoprotein expression in childhood acute lymphoblastic leukemia: no evidence of prognostic impact in follow-up. Pediatric Hematology and Oncology, 18, 27 36.
24. Kiriyama, Y., Kubota, M., Takimoto, T., Kitoh, T., Tanizawa, A., Akiyama, Y. Mikawa, H. (1989) Biochemical characterization of U937 cells resistant to L-asparaginase: the role of asparagine synthetase. Leukemia, 3, 294 297.
25. Li, X., Smyth, A.P., Barrett, D.J., Ivy, S.P. von Hofe, E. (1997) Sensitization of multidrug-resistant human leukemia cells with MDR1-targeted antisense and inhibition of drug-mediated MDR1 induction. Leukemia, 11, 950 957.
26. Liu, Z.L., Onda, K., Tanaka, S., Toma, T., Hirano, T. Oka, K. (2002) Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA. Cancer Chemotherapy and Pharmacology, 49, 391 397.
27. Manabe, A., Coustan-Smith, E., Behm, F.G., Raimondi, S.C. Campana, D. (1992) Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia. Blood, 79, 2370 2377.
28. McGrath, T., Marquardt, D. Center, M.S. (1989) Multiple mechanisms of adriamycin resistance in the human leukemia cell line CCRF-CEM. Biochemical Pharmacology, 38, 497 501.
29. Miyachi, H., Takemura, Y., Yonekura, S., Komatsuda, M., Nagao, T., Arimori, S. Ando, Y. (1993) MDR1 (multidrug resistance) gene expression in adult acute leukemia: correlations with blast phenotype. International Journal of Hematology, 57, 31 37.
30. Munteanu, E., Verdier, M., Grandjean-Forestier, F., Stenger, C., Jayat-Vignoles, C., Huet, S., Robert, J. Ratinaud, M.H. (2006) Mitochondrial localization and activity of P-glycoprotein in doxorubicin-resistant K562 cells. Biochemical Pharmacology, 71, 1162 1174.
31. Nachman, J., Sather, H.N., Cherlow, J.M., Sensel, M.G., Gaynon, P.S., Lukens, J.N., Wolff, L. Trigg, M.E. (1998) Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group. Journal of Clinical Oncology, 16, 920 930.
32. Panosyan, E.H., Seibel, N.L., Martin-Aragon, S., Gaynon, P.S., Avramis, I.A., Sather, H., Franklin, J., Nachman, J., Ettinger, L.J., La, M., Steinherz, P., Cohen, L.J., Siegel, S.E. Avramis, V.I. (2004) Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: Children's Cancer Group Study CCG-1961. Journal of Pediatric Hematology/oncology, 26, 217 226.
33. Pfaffl, M.W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research, 29, e45.
34. Pieters, R., Huismans, D.R., Loonen, A.H., Peters, G.J., Hahlen, K., van der Does-van den Berg, A., van Wering, E.R. Veerman, A.J. (1992) Adenosine deaminase and purine nucleoside phosphorylase in childhood lymphoblastic leukemia: relation with differentiation stage, in vitro drug resistance and clinical prognosis. Leukemia, 6, 375 380.
35. Pieters, R., den Boer, M.L., Durian, M., Janka, G., Schmiegelow, K., Kaspers, G.J., van Wering, E.R. Veerman, A.J. (1998) Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia - implications for treatment of infants. Leukemia, 12, 1344 1348.
36. Prager, M.D. Bachynsky, N. (1968a) Asparagine synthetase in asparaginase resistant and susceptible mouse lymphomas. Biochemical and Biophysical Research Communications, 31, 43 47.
37. Prager, M.D. Bachynsky, N. (1968b) Asparagine synthetase in normal and malignant tissues: correlation with tumor sensitivity to asparaginase. Archives of Biochemistry and Biophysics, 127, 645 654.
38. Pui, C.H. Evans, W.E. (2006) Treatment of acute lymphoblastic leukemia. New England Journal of Medicine, 354, 166 178.
39. Pui, C.H., Relling, M.V., Campana, D. Evans, W.E. (2002) Childhood acute lymphoblastic leukemia. Reviews in Clinical and Experimental Hematology, 6, 161 180 discussion, 200 162.
40. Sonneveld, P. (2000) Multidrug resistance in haematological malignancies. Journal of Internal Medicine, 247, 521 534.
41. Styczynski, J., Pieters, R., Huismans, D.R., Schuurhuis, G.J., Wysocki, M. Veerman, A.J. (2000) In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia. British Journal of Haematology, 110, 813 818.
42. Sugiyama, R.H., Arfin, S.M. Harris, M. (1983) Properties of asparagine synthetase in asparagine-independent variants of Jensen rat sarcoma cells induced by 5-azacytidine. Molecular and Cellular Biology, 3, 1937 1942.
43. Tafuri, A., Gregorj, C., Petrucci, M.T., Ricciardi, M.R., Mancini, M., Cimino, G., Mecucci, C., Tedeschi, A., Fioritoni, G., Ferrara, F., Di Raimondo, F., Gallo, E., Liso, V., Fabbiano, F., Cascavilla, N., Pizzolo, G., Camera, A., Pane, F., Lanza, F., Cilloni, D., Annino, L., Vitale, A., Vegna, M.L., Vignetti, M., Foa, R. Mandelli, F. (2002) MDR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia. Blood, 100, 974 981.
44. Uckun, F.M., Sensel, M.G., Sun, L., Steinherz, P.G., Trigg, M.E., Heerema, N.A., Sather, H.N., Reaman, G.H. Gaynon, P.S. (1998) Biology and treatment of childhood T-lineage acute lymphoblastic leukemia. Blood, 91, 735 746.
45. Wang, X. Seed, B. (2003) A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Research, 31, e154.
46. Winter, S.S., Jiang, Z., Khawaja, H. M., Griffin, T., Devidas, M., Asselin, B.L. Larson, R.S. (2007) Identification of genomic classifiers that distinguish induction failure in T-lineage acute lymphoblastic leukemia: a Children's Oncology Group study. Blood, 110, 1429 1438.
47. Wuchter, C., Ruppert, V., Schrappe, M., Dorken, B., Ludwig, W.D. Karawajew, L. (2002) In vitro susceptibility to dexamethasone- and doxorubicin-induced apoptotic cell death in context of maturation stage, responsiveness to interleukin 7, and early cytoreduction in vivo in childhood T-cell acute lymphoblastic leukemia. Blood, 99, 4109 4115.